首页> 外文期刊>Bulletin of experimental biology and medicine >Characterization of immunogenic properties of polyclonal T cell vaccine intended for the treatment of rheumatoid arthritis
【24h】

Characterization of immunogenic properties of polyclonal T cell vaccine intended for the treatment of rheumatoid arthritis

机译:用于治疗类风湿关节炎的多克隆T细胞疫苗的免疫原性表征

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Two-staged technology for obtaining polyclonal T cell vaccine intended for the treatment of rheumatoid arthritis is described. Stage 1 includes antigen-dependent cultural selection of patient's T cells and stage 2 consists in their reproduction in the needed amounts by nonspecific mitogenic stimulation. T cell vaccination induces an effective specific anti-idiotypic immune response against T cells reactive to joint antigens. Vaccine therapy significantly reduces plasma level of IFN-γ and increases IL-4 level. The results indicate immunological efficiency and safety of polyclonal T cell vaccine in patients with rheumatoid arthritis.
机译:描述了用于获得用于治疗类风湿性关节炎的多克隆T细胞疫苗的两阶段技术。第1阶段包括对患者T细胞的抗原依赖性培养选择,第2阶段包括通过非特异性促有丝分裂刺激以所需量繁殖。 T细胞疫苗接种可诱导针对与关节抗原反应的T细胞的有效特异性抗独特型免疫反应。疫苗疗法可显着降低血浆中IFN-γ的水平并增加IL-4的水平。结果表明类风湿关节炎患者的多克隆T细胞疫苗的免疫有效性和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号